Literature DB >> 157852

Psoriasiform eruption induced by propranolol.

S Halevy, E J Feuerman.   

Abstract

The appearance of a psoriasiform eruption in a seventy-eight year old patient after one year of treatment with propranolol is presented herein. The histologic picture was not compatible with psoriasis vulgaris, although it contained some of the same features. Immunologic investigation revealed immune deposits at the junction of the dermis and epidermis and in blood vessel walls as well as monoclonal gammopathy. The rash, which was followed by a reduction in tear secretion, is suggested to have been a drug reaction associated with propranolol. This is supported by the positive results of a migration inhibiting factor test towards propranolol, the clearing of the eruption which took place three weeks after withdrawal of the drug, and the negative result of the same test obtained soon afterwards.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 157852

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  5 in total

1.  Psoriasis and psoriasiform eruptions associated with propranolol--the role of an immunological mechanism.

Authors:  S Halevy; E Livni
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Is chemotactic activity of polymorphonuclear leukocytes increased in psoriasis?

Authors:  A Langner; T P Chorzelski; M Fraczykowska; S Jabłońska
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

Review 3.  Cutaneous Adverse Effects of Neurologic Medications.

Authors:  Eman Bahrani; Chloe E Nunneley; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 6.497

4.  Triggering drug use in patients with psoriasis: an investigative report from Turkey.

Authors:  Zerrin Ogretmen; Ulku Askin; Meliha Merve Hiz; Sibel Cevizci
Journal:  Postepy Dermatol Alergol       Date:  2014-10-22       Impact factor: 1.837

Review 5.  Is Metformin a Possible Beneficial Treatment for Psoriasis? A Scoping Review.

Authors:  Ana Maria Alexandra Stanescu; Anca Angela Simionescu; Mira Florea; Camelia Cristina Diaconu
Journal:  J Pers Med       Date:  2021-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.